How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code MID: System, Test, Anticardiolipin Immunological. View classification details, related manufacturers, 510(k) clearances, and recall records.
94 clearance records and 17 recall records in the covered releases, across 38 source company names and 1 product codes. Dated history runs from Nov 19, 1991 to Dec 17, 2024.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| MID · System, Test, Anticardiolipin Immunological | 94 | 17 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| AESKULISA CARDIOLIPIN AGMK040463 · MID | Aesku, Inc. | 510(k) | May 12, 2004FDA decision date |
| REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139K032868 · MID | Corgenix, Inc. | 510(k) | Oct 14, 2003FDA decision date |
| BINDAZYME HUMAN ANTI-PHOSPHATIDYLSERINE IGA, IGG AND IGM ENZYME IMMUNOASSAY KITK032240 · MID | The Binding Site, Ltd. | 510(k) | Sep 29, 2003FDA decision date |
| Anti-Cardiolipin IgA ELISA test kit. Product is manufactured by Zeus Scientific, Branchburg, NJ for Sigma Diagnostics, Inc., Saint Louis, MO.Z-1147-03 · MID | Zeus Scientific Inc | Recall | Aug 21, 2003FDA classification date |
| Bindazyme, Human AntiCardiolipin IgM Enzyme Immunoassay Kits, MK029Z-0950-03 · MID | Binding Site Inc The | Recall | Jun 21, 2003FDA classification date |
| AUTOSTAT II ANTI-CARDIOLIPIN IGA ELISAK030741 · MID | Hycor Biomedical , Ltd. | 510(k) | May 1, 2003FDA decision date |
| MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KITK024195 · MID | Corgenix, Inc. | 510(k) | Jan 3, 2003FDA decision date |
| REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK024196 · MID | Corgenix, Inc. | 510(k) | Jan 3, 2003FDA decision date |
| VARELISA CARDIOLIPIN ANTIBODIES SCREEN, MODELS 15848 AND 15896K023433 · MID | Pharmacia Diagnostics GmbH & Co. KG | 510(k) | Nov 13, 2002FDA decision date |
| REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001K022990 · MID | Corgenix, Inc. | 510(k) | Sep 25, 2002FDA decision date |
| REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001K022992 · MID | Corgenix, Inc. | 510(k) | Sep 25, 2002FDA decision date |
| APL IGA ELISA KITK021398 · MID | Louisville Apl Diagnostics, Inc. | 510(k) | Aug 27, 2002FDA decision date |
| QACA IGG/IGM ELISA KIT HRPK021192 · MID | Cheshire Diagnostics , Ltd. | 510(k) | May 16, 2002FDA decision date |
| VARELISA CARDIOLIPIN IGG ANTIBODIES, MODELS 15548 & 15596K020752 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
| VARELISA CARDIOLIPIN IGA ANTIBODIES, MODELS 15748 & 15796K020757 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
| VARELISA CARDIOLIPIN IGM ANTIBODIES, MODELS 15648 & 15696K020758 · MID | Pharmacia Deutschland GmbH | 510(k) | May 2, 2002FDA decision date |
| QACA IGG/IGM ELISA KITK020241 · MID | Cheshire Diagnostics , Ltd. | 510(k) | Mar 13, 2002FDA decision date |
| DIASTAT TOTAL ANTI-CARDIOLIPIN, MODEL FCAR 100TK020156 · MID | Axis-Shield Diagnostics, Ltd. | 510(k) | Mar 6, 2002FDA decision date |
| DIAMEDIX IS-ANTI-CARDIOLIPIN IGG/IGM TEST SYSTEMK012449 · MID | Diamedix Corp. | 510(k) | Oct 26, 2001FDA decision date |
| DIAMEDIX IS-ANTI-CARDIOLIPIN IGA TEST SYSTEMK012450 · MID | Diamedix Corp. | 510(k) | Oct 26, 2001FDA decision date |
| REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTITIVE TEST KITK013018 · MID | Corgenix, Inc. | 510(k) | Sep 20, 2001FDA decision date |
| MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK012567 · MID | Corgenix, Inc. | 510(k) | Aug 23, 2001FDA decision date |
| DIAMEDIX IS-ANTI-CARDIOLIPIN SCREEN TEST SYSTEMK012053 · MID | Diamedix Corp. | 510(k) | Aug 20, 2001FDA decision date |
| ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEMK003069 · MID | Quest Intl., Inc. | 510(k) | Nov 27, 2000FDA decision date |
| DIASTAT ANTI-CARDIOLIPIN IGA, MODEL FCAR 500K001981 · MID | Axis-Shield , Ltd. | 510(k) | Aug 21, 2000FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.